Systematic review of economic evaluations of aromatase inhibitors in estrogen receptor-positive breast cancer: quality evaluation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Systematic review of economic evaluations of aromatase inhibitors in estrogen receptor-positive breast cancer: quality evaluation ; volume:23 ; number:1 ; day:26 ; month:6 ; year:2023 ; pages:1-9 ; date:12.2023
BMC health services research ; 23, Heft 1 (26.6.2023), 1-9, 12.2023
- Creator
-
Althuwaibi, Maha F.
Fernandez-Garcia, Cristina
Hayes, Louise
McNally, Richard
Coughlan, Diarmuid
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12913-023-09432-5
- URN
-
urn:nbn:de:101:1-2023092711234892495175
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Althuwaibi, Maha F.
- Fernandez-Garcia, Cristina
- Hayes, Louise
- McNally, Richard
- Coughlan, Diarmuid
- SpringerLink (Online service)
Other Objects (12)
Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
Aromatase inhibitors
Aromatase inhibitors
Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer
Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells
Inhibitory effects of aromatase inhibitor on estrogen receptor-alpha positive ovarian cancer in mice
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers
Targeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell death
Aromatase inhibitors in post-menopausal endometriosis
Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
New steroidal aromatase inhibitors: Suppression of estrogen-dependent breast cancer cell proliferation and induction of cell death
The impact of CBP expression in estrogen receptor-positive breast cancer
Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
Aromatase inhibitors
Aromatase inhibitors
Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer
Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells
Inhibitory effects of aromatase inhibitor on estrogen receptor-alpha positive ovarian cancer in mice
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers
Targeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell death
Aromatase inhibitors in post-menopausal endometriosis
Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
New steroidal aromatase inhibitors: Suppression of estrogen-dependent breast cancer cell proliferation and induction of cell death
The impact of CBP expression in estrogen receptor-positive breast cancer
Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
Aromatase inhibitors
Aromatase inhibitors
Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer
Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells
Inhibitory effects of aromatase inhibitor on estrogen receptor-alpha positive ovarian cancer in mice
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers
Targeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell death
Aromatase inhibitors in post-menopausal endometriosis
Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
New steroidal aromatase inhibitors: Suppression of estrogen-dependent breast cancer cell proliferation and induction of cell death